Detalhe da pesquisa
1.
Functional genomic landscape of acute myeloid leukaemia.
Nature
; 562(7728): 526-531, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333627
2.
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.
Haematologica
; 107(1): 77-85, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375770
3.
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proc Natl Acad Sci U S A
; 114(36): E7554-E7563, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784769
4.
Assessing Trends in Tobacco Cessation in Diverse Patient Populations.
Nicotine Tob Res
; 18(3): 275-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25921356
5.
Keys to drug sensitivity from updated functional work flows.
Haematologica
; 105(6): 1468-1470, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482750
6.
Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity.
iScience
; 27(5): 109693, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689642
7.
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia.
Clin Cancer Res
; 30(10): 2245-2259, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451486
8.
IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
J Immunol
; 186(3): 1495-502, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21172868
9.
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.
Blood Cancer Discov
; 4(6): 452-467, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698624
10.
IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.
J Immunol
; 185(9): 5453-62, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20921529
11.
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.
Blood Adv
; 6(10): 3062-3067, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078224
12.
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.
Cell Death Dis
; 13(3): 246, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296646
13.
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.
Mol Cancer Ther
; 21(7): 1125-1135, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499387
14.
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell
; 40(8): 850-864.e9, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868306
15.
Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner.
Clin Cancer Res
; 27(17): 4910-4922, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233959
16.
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.
NPJ Precis Oncol
; 5(1): 71, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302041
17.
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.
Leukemia
; 34(9): 2342-2353, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094466
18.
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.
Clin Cancer Res
; 26(24): 6535-6549, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988967
19.
Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders.
Clin Infect Dis
; 48(11): 1541-6, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19405866
20.
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.
Leuk Res
; 77: 42-50, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642575